Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Syed Wamique Yusuf, Nasreen A Ilias-Khan & Jean-Bernard Durand. (2011) Chemotherapy-induced cardiomyopathy. Expert Review of Cardiovascular Therapy 9:2, pages 231-243.
Read now
Read now
Herbert B Newton. (2003) Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: growth factor and Ras signaling pathways. Expert Review of Anticancer Therapy 3:5, pages 595-614.
Read now
Read now
Herbert B Newton. (2002) Chemotherapy for the treatment of metastatic brain tumors. Expert Review of Anticancer Therapy 2:5, pages 495-506.
Read now
Read now
Michael L Salgaller. (2002) The development of immunotherapies for non-small cell lung cancer. Expert Opinion on Biological Therapy 2:3, pages 265-278.
Read now
Read now
Articles from other publishers (47)
Herbert B. Newton, Ramya Tadipatri & Ekokobe Fonkem. 2022. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
25
37
.
Herbert B. Newton, Seema Shroff & Mark G. Malkin. 2022. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy
79
95
.
Herbert B. Newton. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
527
543
.
Caterina Ieran?, Luigi Portella, Sara Lusa, Giuseppina Salzano, Crescenzo D'Alterio, Maria Napolitano, Maria Buoncervello, Daniele Macchia, Massimo Spada, Antonio Barbieri, Antonio Luciano, Maria Vittoria Barone, Lucia Gabriele, Michele Caraglia, Claudio Arra, Giuseppe De Rosa & Stefania Scala. (2016) CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis. Nanoscale 8:14, pages 7562-7571.
Crossref
Crossref
Herbert B. Newton. 2016. Handbook of Neuro-Oncology Neuroimaging. Handbook of Neuro-Oncology Neuroimaging
23
33
.
Kim-Lien Nguyen, Rami Alrezk, Pejman G. Mansourian, Arash Naeim, Matthew B. Rettig & Cathy C. Lee. (2015) The Crossroads of Geriatric Cardiology and Cardio-Oncology. Current Geriatrics Reports 4:4, pages 327-337.
Crossref
Crossref
Herbert B. Newton & Jose J. Otero. 2015. Epilepsy and Brain Tumors. Epilepsy and Brain Tumors
29
43
.
Mario Nava-Villalba & Carmen Aceves. (2014) 6-Iodolactone, key mediator of antitumoral properties of iodine. Prostaglandins & Other Lipid Mediators 112, pages 27-33.
Crossref
Crossref
Dolores Remedios Serrano Lopez & Aikaterini Lalatsa. 2013. Fundamentals of Pharmaceutical Nanoscience. Fundamentals of Pharmaceutical Nanoscience
337
374
.
M. Ingargiola, C. Dittfeld, R. Runge, M. Zenker, J.-M. Heldt, J. Steinbach, N. Cordes, M. Baumann, J. Kotzerke & L. A. Kunz-Schughart. (2012) Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation. Cytometry Part A 81A:10, pages 865-873.
Crossref
Crossref
John Cannon. 2011. Drug Delivery Systems, Third Edition. Drug Delivery Systems, Third Edition
47
78
.
Donald J. AbrahamSoumitra Basu & Adegboyega Oyelere. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
535
568
.
Herbert B. Newton. 2010. Glioblastoma. Glioblastoma
1
42
.
Valerie Humblet, Preeti Misra, Kumar R. Bhushan, Khaled Nasr, Yao-Sen Ko, Takashi Tsukamoto, Nadine Pannier, John V. Frangioni & Wolfgang Maison. (2008) Multivalent Scaffolds for Affinity Maturation of Small Molecule Cell Surface Binders and Their Application to Prostate Tumor Targeting. Journal of Medicinal Chemistry 52:2, pages 544-550.
Crossref
Crossref
Robert O. Dillman. 2009. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy
303
406
.
Yadong Wei, Cishan Li, Wei Huang, Bing Li, Scott Strome & Lai-Xi Wang. (2008)
Glycoengineering of Human IgG1-Fc through Combined Yeast Expression and
in Vitro
Chemoenzymatic Glycosylation
. Biochemistry 47:39, pages 10294-10304.
Crossref
Crossref
Xuhui Zhou, Weiguo Hu & Xuebin Qin. (2008) The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy. The Oncologist 13:9, pages 954-966.
Crossref
Crossref
Barrett W. Newsome & Marc S. Ernstoff. (2008) The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?. British Journal of Clinical Pharmacology 66:1, pages 6-19.
Crossref
Crossref
Syed Wamique Yusuf, Peter Razeghi & Edward T.H. Yeh. (2008) The Diagnosis and Management of Cardiovascular Disease in Cancer Patients. Current Problems in Cardiology 33:4, pages 163-196.
Crossref
Crossref
Wouter HP Driessen, Nobutaka Fujii, Hirokazu Tamamura & Sean M Sullivan. (2008) Development of Peptide-targeted Lipoplexes to CXCR4-expressing Rat Glioma Cells and Rat Proliferating Endothelial Cells. Molecular Therapy 16:3, pages 516-524.
Crossref
Crossref
Herbert B. Newton, Abhik Ray-Chaudhury & Mark G. Malkin. 2008. Handbook of Neuro-Oncology NeuroImaging. Handbook of Neuro-Oncology NeuroImaging
20
30
.
Arati V. Rao & Kenneth Schmader. (2007) Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults. The American Journal of Geriatric Pharmacotherapy 5:3, pages 247-262.
Crossref
Crossref
Leslie E. Silberstein & Melody J. Cunningham. 2007. Blood Banking and Transfusion Medicine. Blood Banking and Transfusion Medicine
557
570
.
Malay Chatterjee, Tridib Chakraborty & Pierfrancesco Tassone. (2006) Multiple myeloma: Monoclonal antibodies-based immunotherapeutic strategies and targeted radiotherapy. European Journal of Cancer 42:11, pages 1640-1652.
Crossref
Crossref
Magda Mahmoud El-Araby .Abla Hassan Nassar .Hanan Farid Shaaban .. (2006) A Possible Role of Triosephosphate/Phosphate Translocator of Chloroplast Envelope Membrane in the Responses of Tomato Plants to Salinity. International Journal of Botany 2:2, pages 177-186.
Crossref
Crossref
Herbert B. Newton. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy
475
489
.
Yolanda Gutierrez-Puente, Arturo Chavez-Reyes, Saroj Vadhan-Raj, Xinsheng Liao, James Murray & Paula Trahan-Rieger. 2005. Acute Care of the Cancer Patient. Acute Care of the Cancer Patient
69
91
.
Incheol Shin, Jeniffer Edl, Swati Biswas, P. Charles Lin, Raymond Mernaugh & Carlos L. Arteaga. (2005) Proapoptotic Activity of Cell-Permeable Anti-Akt Single-Chain Antibodies. Cancer Research 65:7, pages 2815-2824.
Crossref
Crossref
David C. Chhieng, Cristina Rodriguez-Burford & William E. Grizzle. 2005. Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma. Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma
465
471
.
Pierfrancesco TassoneVictor S. GoldmacherPaola NeriAntonella GozziniMasood A. ShammasKathleen R. WhitemanLinda L. Hylander-GansDaniel R. CarrascoTeru HideshimaReshma ShringarpureJialan ShiCharles K. AllamJohn WijdenesSalvatore VenutaNikhil C. MunshiKenneth C. Anderson. (2004) Cytotoxic activity of the maytansinoid immunoconjugate B-B4–DM1 against CD138+ multiple myeloma cells. Blood 104:12, pages 3688-3696.
Crossref
Crossref
Erkan Baloglu, Michael L. Miller, Elizabeth E. Roller, Emily E. Cavanagh, Barbara A. Leece, Victor S. Goldmacher & Ravi V.J. Chari. (2004) Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumors. Bioorganic & Medicinal Chemistry Letters 14:23, pages 5885-5888.
Crossref
Crossref
Pierfrancesco Tassone, Antonella Gozzini, Victor Goldmacher, Masood A. Shammas, Kathleen R. Whiteman, Daniel R. Carrasco, Cheng Li, Charles K. Allam, Salvatore Venuta, Kenneth C. Anderson & Nikhil C. Munshi. (2004)
In Vitro
and
in Vivo
Activity of the Maytansinoid Immunoconjugate huN901-
N
2′-Deacetyl-
N
2′-(3-Mercapto-1-Oxopropyl)-Maytansine against CD56+ Multiple Myeloma Cells
. Cancer Research 64:13, pages 4629-4636.
Crossref
Crossref
Edward T.H. YehAnn T. TongDaniel J. LenihanS. Wamique YusufJoseph SwaffordChristopher ChampionJean-Bernard DurandHarry GibbsAlireza Atef ZafarmandMichael S. Ewer. (2004) Cardiovascular Complications of Cancer Therapy. Circulation 109:25, pages 3122-3131.
Crossref
Crossref
Gerhard Gebauer, Natalia Mueller, Tanja Fehm, Alexander Berkholz, Eberhard P Beck, Wolfram Jaeger & Peter Licht. (2004) Expression and regulation of luteinizing hormone/human chorionic gonadotropin receptors in ovarian cancer and its correlation to human chorionic gonadotropin–doxorubicin sensitivity. American Journal of Obstetrics and Gynecology 190:6, pages 1621-1628.
Crossref
Crossref
David C Chhieng, Cristina Rodriguez-Burford, Lynya I Talley, Helena Sviglin, Cecil R Stockard, Marc J Kleinberg, Mack N Barnes, Edward E Partridge, M.B Khazaeli & William E Grizzle. (2003) Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma. Human Pathology 34:10, pages 1016-1021.
Crossref
Crossref
Vasant Ranade & Mannfred Hollinger. 2003. Drug Delivery Systems, Second Edition. Drug Delivery Systems, Second Edition.
Maria Liljefors, Bo Nilsson, Anna-Lena Hjelm Skog, Peter Ragnhammar, Håkan Mellstedt & Jan-Erik Frödin. (2003) Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A. International Journal of Cancer 105:5, pages 717-723.
Crossref
Crossref
Svetlana O Doronina, Brian E Toki, Michael Y Torgov, Brian A Mendelsohn, Charles G Cerveny, Dana F Chace, Ron L DeBlanc, R Patrick Gearing, Tim D Bovee, Clay B Siegall, Joseph A Francisco, Alan F Wahl, Damon L Meyer & Peter D Senter. (2003) Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Nature Biotechnology 21:7, pages 778-784.
Crossref
Crossref
Costas M. Pitsillides, Edwin K. Joe, Xunbin Wei, R. Rox Anderson & Charles P. Lin. (2003) Selective Cell Targeting with Light-Absorbing Microparticles and Nanoparticles. Biophysical Journal 84:6, pages 4023-4032.
Crossref
Crossref
Alexandar Tzankov. (2003) Retinoic Acid-Induced Golgi Apparatus Disruption in F2000 Fibroblasts: A Model for Enhanced Intracellular Retrograde Transport. BMB Reports 36:3, pages 265-268.
Crossref
Crossref
Vladimir P. Torchilin, Anatoly N. Lukyanov, Zhonggao Gao & Brigitte Papahadjopoulos-Sternberg. (2003) Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. Proceedings of the National Academy of Sciences 100:10, pages 6039-6044.
Crossref
Crossref
Mike Whelan, Joseph Whelan, Nick Russell & Angus Dalgleish. (2003) Cancer immunotherapy: an embarrassment of riches?. Drug Discovery Today 8:6, pages 253-258.
Crossref
Crossref
Vladimir P. Torchilin & Anatoly N. Lukyanov. (2003) Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discovery Today 8:6, pages 259-266.
Crossref
Crossref
Soumitra Basu & Adegboyega K. Oyelere. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery.
Damon L. Meyer & Peter D. Senter. 2003.
229
237
.
B. Ramjiawan, R.E. Ariano, H.H. Mantsch, P. Maiti & M. Jackson. (2002) Immunofluorescence imaging as a tool for studying the pharmacokinetics of a human monoclonal single chain fragment antibody. IEEE Transactions on Medical Imaging 21:10, pages 1317-1323.
Crossref
Crossref
Theresa M. Allen. (2002) Ligand-targeted therapeutics in anticancer therapy. Nature Reviews Cancer 2:10, pages 750-763.
Crossref
Crossref